Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.655 USD | +2.53% | -4.10% | +9.86% |
May. 07 | Inozyme Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 08 | Transcript : Inozyme Pharma, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.86% | 281M | |
+22.82% | 44.96B | |
+1.09% | 42.65B | |
+45.89% | 41.85B | |
-4.27% | 29.04B | |
+11.14% | 26.08B | |
-21.29% | 19.03B | |
+6.51% | 12.75B | |
+28.65% | 12.06B | |
-3.98% | 11.75B |
- Stock Market
- Equities
- INZY Stock
- News Inozyme Pharma, Inc.
- Wedbush Lowers Inozyme Pharma's Price Target to $15 From $20, Keeps Outperform Rating